Healthcare workers are exposed to hazardous drugs such as antineoplastic drugs, which have potential carcinogenic, mutagenic and teratogenic effects. Protective measures must be taken after appropriate staff training to handle antineoplastic drugs in a safe way. The objective was to assess perception, knowledge, practices and training regarding the risk of exposure of healthcare workers in three French compounding units.
Methods
This descriptive study was based on a questionnaire made of 33 questions divided into five sections related to the handling of antineoplastic drugs: perception of the risks, knowledge of the risks, protection practices, specific training and general questions.
Results
Among the 39 participants, over half considered their overall risk of exposure to antineoplastic drugs not being very low. Inhalation was known to 69.2% of them as possible route of contamination. The breakroom was identified by 28.9% of them as a place of contamination. The procedure in case of accidental exposure to antineoplastic drugs was known by 69.2%, but only half could explain it. Only 38.5% said they changed their gloves every 30 min as recommended. Barely half said that they had been trained specifically for the handling of antineoplastic drugs during an initial training. Over half wished to be informed, trained and aware of the proper handling of antineoplastic drugs.
Conclusion
Although some of these results are encouraging, specifically when compared to the other settings where antineoplastic drugs are handled, there is still room for improvement. Efforts to build an adapted and impactful training program must pursue.
ConnorTHLawsonCCPolovichM, et al.Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence. J Occup Environ Med2014; 56: 901–910.
3.
VillariniMGianfrediVLevoratoS, et al.Occupational exposure to cytostatic/antineoplastic drugs and cytogenetic damage measured using the lymphocyte cytokinesis-block micronucleus assay: a systematic review of the literature and meta-analysis. Mutat Res2016; 770: 35–45.
4.
HonC-YTeschkeKChuW, et al.Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals. J Occup Environ Hyg2013; 10: 374–383.
5.
JeronimoMArnoldSAstrakianakisG, et al.Spatial and temporal variability in antineoplastic drug surface contamination in cancer care centers in Alberta and Minnesota. Ann Work Expo Health2021; 65: 760–774.
6.
DelafoyCRoussyCHudonA-F, et al.Canadian Monitoring program of the surface contamination with 11 antineoplastic drugs in 122 centers. J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract 2023; 29(2): 338–347.
7.
HonC-YTeschkeKDemersPA, et al.Antineoplastic Drug Contamination on the Hands of Employees Working Throughout the Hospital Medication System. Ann Occup Hyg 2014; 58(6): 761–770.
8.
ChuWCHonC-YDanylukQ, et al.Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning. J Oncol Pharm Pract2012; 18: 46–51.
9.
BláhováLKutaJDoležalováL, et al.The efficiency of antineoplastic drug contamination removal by widely used disinfectants-laboratory and hospital studies. Int Arch Occup Environ Health2021; 94: 1687–1702.
10.
BenoistHBreuilCLe NeindreB, et al.Does equipment change impact blood contamination with irinotecan and its two major metabolites in a centralized cytotoxic pharmacy unit?J Oncol Pharm Pract2020; 26: 1823–1828.
11.
BéchetVBenoistHBeauF, et al.Blood contamination of the pharmaceutical staff by irinotecan and its two major metabolites inside and outside a compounding unit. J Oncol Pharm Pract 2022; 28(4): 777–784.
12.
HonC-YAbusittaD. Causes of health care Workers’ exposure to antineoplastic drugs: an exploratory study. Can J Hosp Pharm2016; 69: 216–223.
13.
HonC-YTeschkeKChuaP, et al.Occupational exposure to antineoplastic drugs: identification of job categories potentially exposed throughout the hospital medication system. Saf Health Work2011; 2: 273–281.
14.
PowerLACoyneJW. ASHP Guidelines on handling hazardous drugs. Am J Health-Syst Pharm AJHP2018; 75: 1996–2031.
SimonNOdouPDecaudinB, et al.Efficiency of degradation or desorption methods in antineoplastic drug decontamination: a critical review. J Oncol Pharm Pract2019; 25: 929–946.
20.
HonC-YTeschkeKShenH. Health care Workers’ knowledge, perceptions, and behaviors regarding antineoplastic drugs: survey from British Columbia, Canada. J Occup Environ Hyg2015; 12: 669–677.
21.
SilverSRSteegeALBoianoJM. Predictors of adherence to safe handling practices for antineoplastic drugs: a survey of hospital nurses. J Occup Environ Hyg 2016; 13(3): 203–212.
22.
NdawS, et al.Exposition professionnelle des personnels de santé hospitaliers aux médicaments cytotoxiques. Biométrologie et mesure de la contamination des surfaces, https://www.inrs.fr/media.html?refINRS=TF%20255(2018, accessed 30 March 2022).
23.
Ben-AmiSShahamJRabinS, et al.The influence of nurses’ knowledge, attitudes, and health beliefs on their safe behavior with cytotoxic drugs in Israel. Cancer Nurs2001; 24: 192–200.
24.
BenoistHEvenoCWilsonS, et al.Perception, knowledge and protective practices for surgical staff handling antineoplastic drugs during HIPEC and PIPAC. Pleura Peritoneum 2022; 7(2): 77–86. DOI: 10.1515/pp-2021-0151.
25.
BenoistHBussonAFaveyrialA, et al.Perception, knowledge, and handling practice regarding the risk of exposure to antineoplastic drugs in oncology day hospitalization units and compounding unit staff. J Oncol Pharm Pract2022: 107815522211038.
26.
ConstantinidisTCVagkaEDallidouP, et al.Occupational health and safety of personnel handling chemotherapeutic agents in Greek hospitals. Eur J Cancer Care (Engl)2011; 20: 123–131.
27.
BoianoJMSteegeALSweeneyMH. Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs. J Occup Environ Hyg2014; 11: 728–740.
SaitoKHovisJK. Use of contact lenses in an industrial environment. J Occup Environ Med2021; 63: e298–e300.
30.
Al-AzzamSIAwawdehBTAlzoubiKH, et al.Compliance with safe handling guidelines of antineoplastic drugs in Jordanian hospitals. J Oncol Pharm Pract2015; 21: 3–9.
31.
DeJoyDMSmithTDWolduH, et al.Effects of organizational safety practices and perceived safety climate on PPE usage, engineering controls, and adverse events involving liquid antineoplastic drugs among nurses. J Occup Environ Hyg2017; 14: 485–493.
32.
PolovichMClarkPC. Factors influencing oncology nurses’ use of hazardous drug safe-handling precautions. Oncol Nurs Forum2012; 39(3): E299–E309.
33.
PolovichM. USP general chapter <800>: considerations for oncology nursing practice. Semin Oncol Nurs2020; 36(3): 151022.
SottaniCGrignaniEOddoneE, et al.Monitoring surface contamination by antineoplastic drugs in Italian hospitals: performance-based hygienic guidance values (HGVs) project. Ann Work Expo Health2017; 61: 994–1002.
36.
HilliquinDTanguayCBussièresJ-F. External contamination of commercial containers by antineoplastic agents: a literature review. Eur J Hosp Pharm2020; 27: 313–314.
37.
Fleury-SouverainSNussbaumerSMattiuzzoM, et al.Determination of the external contamination and cross-contamination by cytotoxic drugs on the surfaces of vials available on the Swiss market. J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract2014; 20: 100–111.
38.
SchierlRHerwigAPfallerA, et al.Surface contamination of antineoplastic drug vials: comparison of unprotected and protected vials. Am J Health-Syst Pharm AJHP2010; 67: 428–429.
39.
KyprianouMKapsouMRaftopoulosV, et al.Knowledge, attitudes and beliefs of Cypriot nurses on the handling of antineoplastic agents. Eur J Oncol Nurs Off J Eur Oncol Nurs Soc2010; 14: 278–282.
40.
LesoVSottaniCSantoconoC, et al.Exposure to antineoplastic drugs in occupational settings: a systematic review of biological monitoring data. Int J Environ Res Public Health2022; 19: 3737.
41.
PirotCBenoistHLagaduS, et al.Impact of low- and high-risk operators handling irinotecan on the blood contamination of health care workers in oncology day care units. J Oncol Pharm Pract2022: 10781552221090964.
42.
LabrècheFOuelletCRobergeB, et al.Occupational exposure to antineoplastic drugs: what about hospital sanitation personnel?Int Arch Occup Environ Health2021; 94: 1877–1888.
43.
BoianoJMSteegeALSweeneyMH. Adherence to Precautionary Guidelines for Compounding Antineoplastic Drugs: A Survey of Nurses and Pharmacy Practitioners. J Occup Environ Hyg 2015; 12(9): 588–602.
44.
KeatCHSooaidNSYunCY, et al.Improving safety-related knowledge, attitude and practices of nurses handling cytotoxic anticancer drug: pharmacists’ experience in a general hospital, Malaysia. Asian Pac J Cancer Prev APJCP2013; 14: 69–73.
45.
CrulMSimons-SandersK. Carry-over of antineoplastic drug contamination in Dutch hospital pharmacies. J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract2018; 24: 483–489.
